Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
10:03am, Wednesday, May 14, 2025
Dermata Therapeutics, Inc. (NASDAQ: DRMA) has disclosed its financial results for the first quarter ending March 31, 2025, highlighting both positive developments and challenges.
Key Financial Highlights:
Operating Expenses: Total operating expenses decreased from $3.2 million (Q1 2024) to $2.3 ...
10:03am, Wednesday, May 14, 2025
Future Vision II Acquisition Corp. (NASDAQ: FVNNU) Overview
Future Vision II Acquisition Corp. is a blank check company that aims to effect a merger, share exchange, or other business combination with one or more businesses. As of March 31, 2025, the company's financials reflect both its operatio...
10:02am, Wednesday, May 14, 2025
Astrotech Corporation (NASDAQ: ASTC) has recently released its quarterly financial results, reflecting both progress and challenges in its operations.
Key Financial Highlights:
Revenue: Reported at $534,000 for Q3 2025, a significant increase from $50,000 in Q3 2024.
Cost of Revenue: Increased t...
10:02am, Wednesday, May 14, 2025
Neonode Inc. (NASDAQ: NEON) has recently filed its quarterly report for the period ending March 31, 2025. Below are key insights and statistical highlights drawn from the company's income statement and financial performance.
Positive Aspects:
Total revenues for Q1 2025 stood at $513,000, though ...
10:01am, Wednesday, May 14, 2025
NetSol Technologies, Inc. (NASDAQ: NTWK) has recently reported its financial results for the quarter ended March 31, 2025, showcasing a mixed performance overall.
Positive Aspects:
Total Net Revenues: Increased to $17.54 million from $15.46 million year-over-year, representing a growth of approx...
10:01am, Wednesday, May 14, 2025
I-ON Digital Corp. (OTCMKTS: IONI) is experiencing significant developments following its acquisition of Orebits, a move that is set to impact its financial performance and growth trajectory. The company specializes in asset-digitization and securitization solutions, leveraging blockchain technol...
10:00am, Wednesday, May 14, 2025
FVCBankcorp, Inc. (NASDAQ: FVCB) Overview
FVCBankcorp has reported its financial results for the quarter ending March 31, 2025, marking significant growth in net income and overall asset base compared to the same quarter in 2024. However, like many financial institutions, it is navigating the cha...
09:04am, Wednesday, May 14, 2025
Creative Realities, Inc. (OTCMKTS: CREX) has reported its financial results for Q1 2025, revealing notable movements in revenue, expenses, and overall financial health. Here are the key takeaways from their recent income statement and operations:
Revenue Decline: Total sales fell to $9.734 milli...
09:04am, Wednesday, May 14, 2025
Indaptus Therapeutics, Inc. (NASDAQ: INDP) Overview
Indaptus Therapeutics is a clinical-stage biotechnology firm focused on developing an innovative anti-cancer and anti-viral immunotherapy. Their lead candidate, Decoy20, is advancing through clinical trials, placing it at the forefront of their ...
09:03am, Wednesday, May 14, 2025
Aprea Therapeutics, Inc. (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on developing targeted cancer treatments through synthetic lethality mechanisms. For the first quarter of 2025, Aprea continues to face significant challenges in both financial performance and clinical d...
09:03am, Wednesday, May 14, 2025
Zoned Properties Reports Q1 2025: Revenue Up 16.4% Despite Rising Interest Expenses and Tenant Risks
Zoned Properties, Inc. (OTCMKTS: ZDPY) has recently released its quarterly financial report for the period ending March 31, 2025. The report highlights both positive and negative aspects of the company's financial performance as it navigates the commercial real estate sector, specifically within ...
09:02am, Wednesday, May 14, 2025
DeFi Development Corp (NASDAQ: JNVR) Overview
DeFi Development Corp, formerly known as Janover Inc., recently published its quarterly report for Q1 2025, revealing critical insights into its financial performance, operations, and stockholder equity.
Key Financial Highlights:
Total Revenues: $287...
09:02am, Wednesday, May 14, 2025
Company Overview
Theriva Biologics, Inc. (NYSE: TOVX) is a clinical-stage biopharmaceutical firm focused on developing innovative therapeutics primarily in oncology. The company has undergone a strategic transformation towards cancer treatment since acquiring VCN Biosciences in March 2022.
Recent...
09:02am, Wednesday, May 14, 2025
Leatt Corporation (OTCMKTS: LEAT)
Leatt Corporation has reported its quarterly results for the period ending March 31, 2025. The income statement reflects significant growth in revenues compared to the same period last year. However, the company also faces challenges that may impact future perfor...
09:01am, Wednesday, May 14, 2025
Company Overview
Urgent.ly Inc. (NASDAQ: ULY) is a connected mobility assistance software platform headquartered in Vienna, Virginia. The company specializes in matching vehicle owners and operators with service professionals for roadside assistance and other related services. As of March 31, 202...